This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow [Supplementary Material]
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mont, M. A.
Right arrow Articles by Hungerford, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mont, M. A.
Right arrow Articles by Hungerford, D. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
The Journal of Bone and Joint Surgery (American) 83:1013-1022 (2001)
© 2001 The Journal of Bone and Joint Surgery, Inc.

Strut-Autografting with and without Osteogenic Protein-1

A Preliminary Study of a Canine Femoral Head Defect Model

Michael A. Mont, MD, Lynne C. Jones, PhD, John J. Elias, PhD, Nozomu Inoue, MD, PhD, Taek-Rim Yoon, MD, Edmund Y.S. Chao, PhD and David S. Hungerford, MD

Investigation performed at the Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland
Michael A. Mont, MD
Institute for Advanced Orthopaedics, Sinai Hospital, 2411 West Belvedere Avenue, Suite 102, Baltimore, MD 21215. E-mail address: rhondamont{at}aol.com

Lynne C. Jones, PhD
John J. Elias, PhD
Nozomu Inoue, MD, PhD
Taek-Rim Yoon, MD
Edmund Y.S. Chao, PhD
David S. Hungerford, MD
Department of Orthopaedic Surgery, The Johns Hopkins University School of Medicine, Good Samaritan Professional Building, 5601 Loch Raven Boulevard, Baltimore, MD 21239

No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. Funds were received in total or partial support of the research or clinical study presented in this article. The funding source was Grant 95-018 from the Orthopaedic Resident and Education Foundation. Stryker Biotech (Hopkinton, Massachusetts) supplied the osteogenic protein-1.

Background: Osteonecrosis of the femoral head frequently leads to collapse of the articular cartilage and to disabling osteoarthritis, which ultimately may necessitate joint arthroplasty. One treatment method that has had moderate success is the so-called trapdoor approach, which involves excavation of diseased (necrotic) bone followed by bone-grafting. Augmentation of this procedure with various growth and differentiation factors may improve the outcome. We developed a canine model that mimics the clinical situation with trapdoor bone-grafting. The objective of this study was to evaluate the effect of the addition of osteogenic protein-1 on healing following the trapdoor procedure with strut-autografting.

Methods: Thirty-four skeletally mature dogs were used in the experiment. After capsulotomy, a trapdoor was created in the anterolateral surface of the femoral head and a 2-cm-diameter subchondral area of bone was removed. In the phase-I experiments, seven dogs had no treatment of the defect (Group I) and nine dogs were treated with strut-grafting (Group II). In phase II, the procedure was modified by collapsing the trapdoor into the created defect intraoperatively in eighteen dogs, which were divided into three equal groups: six untreated defects were left collapsed (Group III), six were treated with bone graft (Group IV), and six were treated with bone graft augmented with osteogenic protein-1 (Group V).

Results: Three of the seven femoral heads in Group I (untreated defect) and one of the nine heads in Group II (grafting without collapsing of the trapdoor) had evidence of cartilage collapse. Inspection of sagittal slices and radiographs revealed an unfilled residual defect in all Group-I heads, whereas all Group-II heads were well healed. The mean normalized stiffness value was significantly larger in Group II than it was in Group I. On visual inspection, depression was noted in all of the femoral heads in Group III (untreated defect; trapdoor left collapsed). In both Group IV and Group V (grafting without and with osteogenic protein-1), the trapdoor cartilage appeared to be essentially normal. Groups IV and V had more radiographic healing than did Group III. The defects in Group V (grafting with osteogenic protein-1) healed faster radiographically than did those in Group IV (grafting without osteogenic protein-1).

Conclusions: Moderate-to-excellent healing was seen both radiographically and biomechanically by four months in the groups treated with grafting, with and without osteogenic protein-1, whereas untreated defects did not heal.

Clinical Relevance: Symptomatic osteonecrosis of the femoral head is a clinical challenge. The animal model in the current study is a useful tool for the evaluation of methods to treat osteonecrosis of the femoral head. Studies investigating additional time-periods between implantation of osteogenic protein-1 and assessment of results as well as different doses of osteogenic protein-1 are warranted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
X. Chen, A. H. Schmidt, D. T. Tsukayama, C. A. Bourgeault, and W. D. Lew
Recombinant Human Osteogenic Protein-1 Induces Bone Formation in a Chronically Infected, Internally Stabilized Segmental Defect in the Rat Femur
J. Bone Joint Surg. Am., July 1, 2006; 88(7): 1510 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
M. A. Mont, L. C. Jones, and D. S. Hungerford
Nontraumatic Osteonecrosis of the Femoral Head: Ten Years Later
J. Bone Joint Surg. Am., May 1, 2006; 88(5): 1117 - 1132.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
M. A. Mont, P. S. Ragland, B. Biggins, G. Friedlaender, T. Patel, S. Cook, G. Etienne, A. Shimmin, R. Kildey, D. C. Rueger, et al.
Use of Bone Morphogenetic Proteins for Musculoskeletal Applications: An Overview
J. Bone Joint Surg. Am., December 1, 2004; 86(suppl_2): 41 - 55.
[Full Text] [PDF]

Home page
 JBJSHome page
M. H. Huo
What's New in Hip Arthroplasty
J. Bone Joint Surg. Am., October 10, 2002; 84(10): 1894 - 1905.
[Full Text] [PDF]